Cellectis S.A.
PLANTS FOR PRODUCTION OF THERAPEUTIC PROTEINS

Last updated:

Abstract:

Materials and methods are provided for making plants (e.g., Nicotiana varieties) that are suitable for producing therapeutic polypeptides suitable for administration to humans and animals, particularly by making TAL effector endonuclease-induced mutations in genes encoding xylosyltransferases and fucosyltransferases.

Status:
Application
Type:

Utility

Filling date:

13 Nov 2020

Issue date:

4 Mar 2021